Objectives Vascular involvement is one of the major causes of morbidity and mortality in
Behçet's disease (BD) patients. Immunosuppressive (IS) agents are the mainstay of vascular …

Behcet's disease (BD) is a polysymptomatic and recurrent systemic vasculitis with a chronic
course and unknown cause. The pathogenesis of BD has not been fully elucidated; …

Abstract Background We hypothesized that Behçet's disease (BD) consists of several clinical
subtypes with different severity, resulting in heterogeneity of the disease. Here, we …

Behçet's disease (BD) is a chronic, multisystemic, inflammatory disease characterized by
recurrent attacks of mucocutaneous, ocular, musculoskeletal, vascular, central nervous …

ABSTRACT A meta-analysis showed that methodological differences in prevalence studies
such as a sample survey design or census design may be responsible for some of the …

Prospective and controlled studies for the management of major organ involvement in
Behçet's disease are still limited. Data from primarily retrospective studies confirmed better …

Objective The pilot study aims to evaluate the effectiveness and safety of baricitinib in
Behcet's Disease (BD) patients with refractory vascular involvement. Methods We …

Objective This study aims to investigate the efficacy and reliability of infliximab treatment in
Behcet's disease with vascular involvement. Methods This single-center retrospective study …

Background: Vascular Behçet's disease (VBD) might involve all sizes of arterial and venous
vessels. Major vascular involvement caused the primary death in Behçet's syndrome (BS) …

Background Behcet's disease (BD) is a chronic immune disease that involves multiple
systems. As the pathogenesis of BD is not clear, and new treatments are needed, we used …